|
|
|
|
Long-term, open-label vagus nerve stimulation (VNS) provided seizure reduction similar to or greater than acute studies, for median reductions and for those reaching a >/=50% seizure reduction. VNS remained safe and well tolerated, with n early three-quarters of the patients choosing to continue therapy. |
|